MySubsidy

Production Linked Incentive (PLI) Scheme for Pharmaceuticals

Ministry of Chemicals and Fertilizers · Central government

A central scheme gives financial incentives on incremental sales of pharmaceuticals and in-vitro diagnostic devices to fund India's domestic manufacturers.

Open, rolling. Applications are accepted continuously — there is no deadline.

Key facts

Subsidy amount
₹15,00,000 – ₹10,00,00,00,000
Instrument
Subsidy
Deadline
Rolling
Disbursement
Released against milestones
Scheme duration
73 months

About this scheme

The Ministry of Chemicals and Fertilizers, through its Department of Pharmaceuticals, introduced the Production Linked Incentive (PLI) Scheme for Pharmaceuticals. Its primary aim is to expand India's pharmaceutical manufacturing capacity by encouraging greater investment and output, and by shifting production towards higher-value goods such as advanced pharmaceutical products and in-vitro diagnostic medical devices.

Incentives under the scheme are calculated on incremental sales over a fixed base year. Through this structure, the scheme intends to position India as a leading player in the global pharmaceutical supply chain.

The Small Industries Development Bank of India (SIDBI) serves as the Project Management Agency (PMA) for the scheme. Applications are processed and incentive disbursements facilitated through a dedicated online portal.

The scheme supports the domestic pharmaceutical ecosystem, encourages innovation, and lowers dependence on imports for critical pharmaceutical ingredients and finished products.

Who can apply

Eligible business forms
Private limited company, Limited liability partnership, One person company, Partnership firm, Sole proprietorship
Udyam registration
Not specified
MSME registration
Not specified
DPIIT startup recognition
Not specified
GST registration
Not specified
Revenue band
From ₹5,00,000
Where the business may be based
Not restricted

- Manufacturer of pharmaceutical goods, registered in India. - Engaged in the manufacture of eligible pharmaceutical products within the three defined categories. - No claim of incentives for the same product under any other PLI scheme. - **Group A:** Global Manufacturing Revenue from pharmaceutical goods or in-vitro Diagnostic Medical Devices of ₹5,000 crores or more in FY 2019-20; minimum cumulative investment of ₹1,000 crores across 5 years; minimum eligible product turnover of ₹50 crores in FY 2022-23. - **Group B:** Global Manufacturing Revenue between ₹500 crores and ₹5,000 crores in FY 2019-20; minimum cumulative investment of ₹250 crores across 5 years; minimum eligible product turnover of ₹10 crores in FY 2022-23. - **Group C:** Global Manufacturing Revenue below ₹500 crores in FY 2019-20; minimum cumulative investment of ₹50 crores across 5 years; minimum eligible product turnover of ₹1 crore in FY 2022-23. - **Group C (MSME):** Falls within the Micro, Small and Medium Enterprises (MSME) category under Group C; commits eligible investment across 5 years; minimum eligible product turnover of ₹50 lakhs in FY 2022-23. - **Continuation:** For FY 2023-24 onwards, sales growth of 7% over the preceding financial year is required to keep claiming incentives.

How to apply

1. **Step 1: Reach the portal:** Go to the official online portal at https://pli-pharma.udyamimitra.in. 2. **Step 2: Sign up and file your application:** Create a registration on the portal, then complete the detailed application form with accurate particulars covering your Global Manufacturing Revenue, investment commitments, and the specific pharmaceutical product categories in which your company operates. 3. **Step 3: Pay the application fee:** Remit the non-refundable application fee at the rate laid down in the scheme guidelines. 4. **Step 4: Wait for processing:** The Project Management Agency (SIDBI) will process the applications received and assess them using a predefined ranking methodology. This selection exercise is usually concluded within 90 days of the application window closing. 5. **Step 5: Approval:** Should your application be selected, the Project Management Agency will issue you an official approval letter. 6. **Step 6: Provide guarantees:** No later than two weeks from the date you receive the approval letter, furnish a Bank Guarantee for the prescribed amount together with an Undertaking in favour of the Department of Pharmaceuticals. 7. **Step 7: Claim incentives each year:** Every year, file your claims for incentive disbursement through the online portal, attaching all supporting documents that are required, within one month of the financial year closing.

Apply on the issuer's site

How applications are assessed

The Project Management Agency (SIDBI) evaluates every application it receives. A pre-defined ranking methodology governs which applicants are selected, taking into account the applicant's Global Manufacturing Revenue, committed investments, and proposed product categories. Applicants can usually expect to hear the outcome within 90 days of the application window closing.

Frequently asked questions

What is the primary goal of the PLI Scheme for Pharmaceuticals?

The scheme seeks to strengthen India's domestic manufacturing, draw in substantial investment, and encourage a shift towards high-value pharmaceutical products and in-vitro diagnostic medical devices, which would lower reliance on imports.

Who is eligible to apply for this PLI scheme?

Manufacturers of pharmaceutical goods registered in India qualify if their products fall within the scheme's three categories, and eligibility further hinges on global manufacturing revenue and committed investment, which sort applicants into Groups A, B and C, with Group C containing a sub-category for MSMEs.

How are the financial incentives calculated and paid out?

Incentives are paid over six years at 3% to 10% of net incremental sales over a base year, with annual claims submitted online. Of each approved claim, 75% is released immediately and the remaining 25% on submission of final audited accounts.

What are the maximum incentives an applicant can receive?

The incentive ceiling per applicant stands at ₹10,000 crore for Group A companies, ₹2,500 crore for Group B companies, and ₹50 crore for Group C companies.

Is MSME registration required for this scheme?

MSMEs are not always required to meet the standard thresholds, as Group C includes a separate eligibility sub-category for Micro, Small and Medium Enterprises; those that satisfy this group's criteria may apply under the relaxed thresholds.

What is the application process for the PLI Pharma Scheme?

Applications are made online through the Project Management Agency (SIDBI) portal, which requires registration, completion of the application form and payment of a non-refundable fee; those selected must then furnish a Bank Guarantee and an Undertaking. Annual incentive claims are likewise filed through the same portal.

Sectors

  • Health Pharma Biotech
  • Pharmaceuticals
  • Pli Scheme
  • Manufacturing
  • Medical Devices
  • Drug Production
  • Incentives
  • Industry Growth

Details last verified on 18 September 2026. Source: the issuer's published information.